Biological Suture Core with Composite Cover for Healing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing surgical sutures made from synthetic materials lack the biocompatibility and enhanced wound healing properties that biological materials like collagen can provide, particularly in promoting tissue regeneration and healing.

Innovation Solution

Development of surgical sutures comprising a core made substantially of biopolymers or proteins, such as collagen, which can be optionally covered with a braided layer and impregnated with biological components like blood, growth factors, or antibiotics to enhance healing, and coated for improved handling and retention at the surgical site.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If synthetic materials are used for surgical sutures, then strength and durability are improved, but biocompatibility and wound healing properties deteriorate

Engineering Contradiction:
Improvesuture strengthVSAvoidbiocompatibility
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The patent applies composite materials by combining synthetic suture material with biological materials (collagen, blood, growth factors) to create a hybrid structure that provides both mechanical strength from the synthetic component and biocompatibility/healing properties from the biological component. The biological material is applied to the synthetic suture through impregnation, coating, or binding, creating a composite structure that resolves the contradiction between strength and biocompatibility.

Inventive Principle:
Principle #40Composite materials

2Reliability

If biological materials like collagen are used for surgical sutures, then biocompatibility and wound healing properties are improved, but strength and durability deteriorate

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidsuture strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent uses composite materials to combine the biocompatibility of biological materials with the strength of synthetic materials. The synthetic suture material provides the mechanical framework and strength, while the biological materials (collagen, blood, growth factors) are applied as coatings or impregnations to provide biocompatibility and healing properties without compromising the underlying structural integrity.

Inventive Principle:
Principle #40Composite materials

3Reliability

If biological material is applied to synthetic suture, then healing properties are improved, but manufacturing complexity increases

Engineering Contradiction:
Improvehealing propertiesVSAvoidmanufacturing simplicity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies preliminary action by pre-applying biological materials to the synthetic suture during the manufacturing process rather than requiring post-manufacturing application. The biological materials are impregnated, coated, or bound to the suture material in controlled manufacturing steps, ensuring uniform distribution and proper integration before the suture is used surgically.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The composite material approach allows for integrated manufacturing where biological and synthetic materials are combined in a single production process. The biological materials are incorporated into the synthetic suture structure through impregnation, coating, or binding techniques that can be performed during manufacturing, creating a ready-to-use composite suture product.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentEP2098253B1Suture with biological material
Publication Date: 2012.02.22 ARTHREX INC
  • EP2098253B1 patent drawingFigure 1~2
  • EP2098253B1 patent drawingFigure 3

AI summary

A surgical suture having a core made substantially of biological material (such as biopolymers or proteins, for example) and a cover surrounding the core. The section comprising the biological material may be provided adjacent at least a section of suture not comprising biological material. The section comprising the biological material may be provided in the form of strands or a matrix or a spongy material, which may be additionally treated with biological components such as blood, blood fractions or components, platelet-rich plasma, autologous conditioned plasma, bone marrow aspirate, growth factors, antiseptics, and antibiotics, among others.